Gibson Dunn Advises Kimberly-Clark on Acquisition of Kenvue

Firm News  |  November 3, 2025

---

Gibson Dunn is advising Kimberly-Clark Corporation on certain legal and healthcare regulatory matters pertaining to its agreement to acquire all the outstanding shares of common stock of Kenvue Inc., a global consumer health leader.

The cash-and-stock transaction — which values Kenvue at an enterprise value of approximately $48.7 billion based on the closing price of Kimberly-Clark common stock on October 31, 2025 — brings together two iconic American companies to create a combined portfolio of complementary products, including 10 billion-dollar brands, that touch nearly half the global population through every stage of life.

Our team includes partners Timothy Loose, Theodore J. Boutrous, Jr., and Amir Tayrani.